| Position: Home>Women Health> |
| Position: Home>Women Health> |
NEW YORK - Women who have their ovaries removed before menopause run a heightened risk of developing dementia or other mental problems later in life — unless they take estrogen until age 50, a new study suggests.
Experts said the research needs to be confirmed by further study, but the findings suggest another issue for premenopausal women and their doctors to discuss as they consider ovary removal.
And if they decide to go ahead with surgery, they need to consider the risks and benefits of taking estrogen to age 50, said Dr. Walter Rocca, a Mayo Clinic neurologist and lead study author.
Hormone therapy has been linked to a greater risk of dementia and heart attacks when given to women after age 65. But recent research indicates that when given before menopause or just afterward, it doesn’t raise heart attack risk and may protect against dementia.
The study did not include women who had ovaries removed as part of cancer treatment, and Rocca said the results do not apply to such women. The work was published Wednesday in the online edition of the journal Neurology.
Ovaries produce estrogen. Rocca said the likeliest explanation of the study results is that removing ovaries causes a sudden deficiency of that hormone, which in turn affects the brain.
Ovaries often removed during hysterectomies
Hundreds of thousands of women have their ovaries removed each year in the United States. In women around age 45, approaching menopause, ovaries are often removed during hysterectomies as a precaution against developing ovarian cancer. In addition, some women at unusually high risk of developing ovarian cancer have ovaries removed without hysterectomies, as do others who have ovarian problems like endometriosis.
Women younger than 45 often take estrogen after ovary removal because of symptoms like hot flashes and concerns about developing osteoporosis, noted Dr. Nancy Chescheir of Vanderbilt University. But older women who have the surgery are less likely to start estrogen therapy, said Chescheir, who didn’t participate in the new research.
The new study found the risk of later mental impairment was higher when the surgery was done at younger ages.
The research examined the fates of about 1,500 women who had one or both ovaries removed from 1950-87, and compared them to about 1,500 other women. Interviewers spoke with either the women themselves or somebody who knew them, asking about signs of memory impairment and any diagnosis of dementia or Alzheimer’s disease.
50 percent increased risk of mental problems
Overall, the study found that women who’d had one or both ovaries removed showed about a 50 percent increase in risk of the later mental problems.
A second study, which included about 2,300 women who’d had the surgery and about 2,400 who hadn’t, found about a 70 percent increased risk for a diagnosis of Parkinson’s disease or Parkinson’s symptoms like tremors.
Still, that outcome was far less common than mental impairment, and experts said the evidence behind it was weaker than that provided in the mental-impairment paper. The Parkinson paper finding is “not quite ready for prime time” in terms of affecting patient care, said Dr. JoAnn Manson, chief of preventive medicine at Harvard’s Brigham and Women’s Hospital. She was not involved with either study.
The mental-impairment paper suggests that a premenopausal woman without a family history of ovarian cancer who has to decide on whether to have her ovaries removed should ask her doctor whether that step is really necessary, she said.
“It’s very reasonable and important to have that conversation with her doctor,” Manson said.
Chescheir noted that estrogen therapy carries its own risks, such as a higher rate of blood clots and breast cancer, but that ovary-removal patients younger than 50 may want to have a serious discussion of that option after surgery.
|
Top Stories
FRIDAY, Feb. 2 (HealthDay News) -- People who spend a lot of time behind the wheel may b
WEDNESDAY, Feb. 7 (HealthDay News) -- A new monoclonal antibody drug produced dramatic i
TUESDAY, Feb. 13 (HealthDay News) -- Many patients with moderate to severe chronic psori
FRIDAY, Feb. 9 (HealthDay News) -- A neuropeptide called melanin concentrating hormone (
MONDAY, Feb. 12 (HealthDay News) -- Extensive genetic analysis has uncovered a gene vari
MONDAY, Feb. 12 (HealthDay News) -- Postmenopausal breast cancer patients who switch fro
|
|
Related
In the year sincePlan Bwas approved for over-the-counter sales, it has become a huge com Dreading your next visit? We can read your mindand help you fight your fears. I hate tho Melissa Dahl Health writer E-mail During her sophomore year of high school, Jennifer Rob TUESDAY, Jan. 16 (HealthDay News) -- More American families -- both with health insuranc
Triplets born to woman with 2 wombs First case of its kind, British hospital official sa
Herbal treatment little help for menopause Black cohosh not effective in relieving hot f
Despite cancer risk, some need hormones Docs worry severely menopausal women with won't
Morning-after pill on shelves, but debate rages Plan B now available at pharmacies natio
|

LOOKING
FOR
ADVERTISEMENT
